Becton, Dickinson and Co. | رأس المال والاحتياطيات



Equity Capital And Reserves تغيير تاريخ
Abbott USD 49.06B 9.04B 2025-03
Agilent USD 6.03B 129M 2025-01
Align Technology USD 3.79B 57.74M 2025-03
Avanos Medical USD 839.4M 10.9M 2025-03
Baxter International USD 6.96B 908M 2024-12
Becton, Dickinson and Co. USD 25.24B 36M 2025-03
Bio-Rad Laboratories USD 6.68B 110.1M 2025-03
Boston Scientific USD 22.21B 443M 2025-03
Cooper Companies USD 8.13B 44.1M 2025-01
Danaher USD 50.85B 1.31B 2025-03
Dentsply International USD 2.01B 68M 2025-03
Dexcom USD 2.27B 164M 2025-03
Edwards Lifesciences USD 10B 452.8M 2024-12
Exact Sciences USD 2.4B 5.34M 2025-03
Globus Medical USD 4.09B 89.26M 2025-03
Hologic USD 4.62B 154.6M 2025-03
Insulet USD 1.33B 119.1M 2025-03
Integra LifeSciences USD 1.52B 21.14M 2025-03
Intuitive Surgical USD 17.21B 678.1M 2025-03
J&J USD 78.11B 6.62B 2025-03
Masimo USD 946.4M 105.5M 2025-03
Medtronic USD 49.39B 893M 2025-01
Solventum Corp 3.26B 303M 2025-03
Stryker USD 20.93B 296M 2025-03
Tandem Diabetes Care USD 155.29M 107.81M 2025-03
Teleflex USD 4.1B 182.98M 2025-03
Terumo JPY 1.37T 35.03B 2025-03
Thermo Fisher Scientific USD 49.36B 227M 2025-03
Zimmer Biomet Holdings USD 12.47B 93.4M 2024-12



Becton, Dickinson and Co. رأس المال والاحتياطيات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.